Silence Therapeutics Plc - ADR Forecast, price target & analysts
Silence Therapeutics Plc - ADR Target price 2025 - Analyst rating & recommendation
Silence Therapeutics Plc - ADR Classifications & Recommendation:
Silence Therapeutics Plc - ADR Price Target
| Target Price | $46.83 |
| Price | $4.72 |
| Potential |
892.22%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Silence Therapeutics Plc - ADR 2026 .
The average Silence Therapeutics Plc - ADR target price is $46.83.
This is
892.22%
register free of charge
$76.53
1,521.31%
register free of charge
$6.13
29.78%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Silence Therapeutics Plc - ADR to buy, 0 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Silence Therapeutics Plc - ADR stock has an average upside potential 2026 of
892.22%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 31.54 | 24.63 |
| 46.29% | 21.92% | |
| EBITDA Margin | -193.53% | -325.04% |
| 29.59% | 67.95% | |
| Net Margin | -217.04% | -100.72% |
| 36.05% | 53.59% |
7 Analysts have issued a sales forecast Silence Therapeutics Plc - ADR 2024 . The average Silence Therapeutics Plc - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Silence Therapeutics Plc - ADR EBITDA forecast 2024. The average Silence Therapeutics Plc - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Silence Therapeutics Plc - ADR 2024 . The average Silence Therapeutics Plc - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.45 | -0.53 |
| 6.45% | 63.45% | |
| P/E | negative | |
| EV/Sales | 2.13 |
1 Analysts have issued a Silence Therapeutics Plc - ADR forecast for earnings per share. The average Silence Therapeutics Plc - ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Silence Therapeutics Plc - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Silence Therapeutics Plc - ADR...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
